ESR1 mutations in metastatic lobular breast cancer patients. (2019)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41523-019-0104-z
PubMed Identifier: 30820448
Publication URI: http://europepmc.org/abstract/MED/30820448
Type: Journal Article/Review
Volume: 5
Parent Publication: NPJ breast cancer
ISSN: 2374-4677